The new guidelines outlined in the ECSA-15-003 describe what information registrants are supposed to provide to the FDA in order to facilitate the review of applications to add electrostatic sprayor application instructions for use against SARS-coV-2. In particular, the guidelines address the need for ECOSHA approval as an additional safety standard. Specifically, the guidelines state that the ECO